Free Trial

ExodusPoint Capital Management LP Buys 21,864 Shares of The Pennant Group, Inc. (NASDAQ:PNTG)

The Pennant Group logo with Medical background

ExodusPoint Capital Management LP increased its position in The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) by 111.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 41,515 shares of the company's stock after purchasing an additional 21,864 shares during the quarter. ExodusPoint Capital Management LP owned 0.12% of The Pennant Group worth $1,101,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Quarry LP increased its position in shares of The Pennant Group by 371.6% in the 3rd quarter. Quarry LP now owns 1,014 shares of the company's stock worth $36,000 after purchasing an additional 799 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new stake in The Pennant Group during the fourth quarter valued at approximately $188,000. HighTower Advisors LLC acquired a new position in shares of The Pennant Group in the 3rd quarter worth approximately $282,000. LPL Financial LLC acquired a new position in shares of The Pennant Group in the 4th quarter worth approximately $225,000. Finally, Arizona State Retirement System raised its position in shares of The Pennant Group by 13.0% during the 4th quarter. Arizona State Retirement System now owns 9,773 shares of the company's stock valued at $259,000 after acquiring an additional 1,121 shares in the last quarter. 85.88% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on PNTG. Truist Financial cut their target price on shares of The Pennant Group from $32.00 to $28.00 and set a "hold" rating on the stock in a report on Friday, March 7th. Stephens restated an "overweight" rating and issued a $38.00 target price on shares of The Pennant Group in a research report on Wednesday, April 2nd. Finally, Wells Fargo & Company began coverage on The Pennant Group in a research note on Thursday, December 19th. They set an "equal weight" rating and a $33.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $34.80.

View Our Latest Stock Analysis on PNTG

The Pennant Group Trading Up 0.6 %

Shares of NASDAQ:PNTG traded up $0.16 during mid-day trading on Wednesday, hitting $26.16. The stock had a trading volume of 19,502 shares, compared to its average volume of 223,555. The company's 50 day moving average is $24.77 and its 200-day moving average is $28.33. The Pennant Group, Inc. has a 12-month low of $19.37 and a 12-month high of $37.13. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.12 and a current ratio of 1.12. The company has a market cap of $908.33 million, a PE ratio of 38.47, a P/E/G ratio of 2.24 and a beta of 1.73.

The Pennant Group Company Profile

(Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Read More

Institutional Ownership by Quarter for The Pennant Group (NASDAQ:PNTG)

Should You Invest $1,000 in The Pennant Group Right Now?

Before you consider The Pennant Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.

While The Pennant Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Sectors With Massive Momentum You Can’t Afford to Miss
Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines